Genotypes
Control(n=160)
Cases (n=160)
OR
*
(95% CI)
CC (ref)
60
33
1
TT
22
52
4.3(2.2-8.3)
CT
78
75
1.7(1.0-3.0)
CT+TT
100
127
2.3(1.4-3.8)
*
OR–Odds ratio
Table 3:
Risk of NSCLC associated with the CASP9 (-712C>T) genotypes.
